BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19909340)

  • 21. Conserved intramolecular disulfide bond is critical to trafficking and fate of ATP-binding cassette (ABC) transporters ABCB6 and sulfonylurea receptor 1 (SUR1)/ABCC8.
    Fukuda Y; Aguilar-Bryan L; Vaxillaire M; Dechaume A; Wang Y; Dean M; Moitra K; Bryan J; Schuetz JD
    J Biol Chem; 2011 Mar; 286(10):8481-8492. PubMed ID: 21199866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
    Hou H; Sun H; Lu P; Ge C; Zhang L; Li H; Zhao F; Tian H; Zhang L; Chen T; Yao M; Li J
    Mol Cancer Ther; 2013 Dec; 12(12):2874-84. PubMed ID: 24130050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin-mediated proteasomal degradation of ABC transporters: a new aspect of genetic polymorphisms and clinical impacts.
    Nakagawa H; Toyoda Y; Wakabayashi-Nakao K; Tamaki H; Osumi M; Ishikawa T
    J Pharm Sci; 2011 Sep; 100(9):3602-19. PubMed ID: 21567408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of human ABC transporter ABCG2: development of the standard method for functional validation of SNPs by using the Flp recombinase system.
    Tamura A; Wakabayashi K; Onishi Y; Nakagawa H; Tsuji M; Matsuda Y; Ishikawa T
    J Exp Ther Oncol; 2006; 6(1):1-11. PubMed ID: 17228519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions.
    Saito H; Hirano H; Nakagawa H; Fukami T; Oosumi K; Murakami K; Kimura H; Kouchi T; Konomi M; Tao E; Tsujikawa N; Tarui S; Nagakura M; Osumi M; Ishikawa T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1114-24. PubMed ID: 16489126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
    Meyer zu Schwabedissen HE; Kroemer HK
    Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human ABC transporter ABCG2 in xenobiotic protection and redox biology.
    Wakabayashi K; Tamura A; Saito H; Onishi Y; Ishikawa T
    Drug Metab Rev; 2006; 38(3):371-91. PubMed ID: 16877258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid.
    Yoshikawa M; Ikegami Y; Sano K; Yoshida H; Mitomo H; Sawada S; Ishikawa T
    J Exp Ther Oncol; 2004 Apr; 4(1):25-35. PubMed ID: 15255290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.
    Niu Q; Wang W; Li Y; Ruden DM; Wang F; Li Y; Wang F; Song J; Zheng K
    PLoS One; 2012; 7(7):e41035. PubMed ID: 22844424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
    Pick A; Wiese M
    ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2.
    Robey RW; Fetsch PA; Polgar O; Dean M; Bates SE
    Res Vet Sci; 2006 Dec; 81(3):345-9. PubMed ID: 16808938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells.
    Asashima T; Hori S; Ohtsuki S; Tachikawa M; Watanabe M; Mukai C; Kitagaki S; Miyakoshi N; Terasaki T
    Pharm Res; 2006 Jun; 23(6):1235-42. PubMed ID: 16715370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
    Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
    J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1).
    Xu Y; Egido E; Li-Blatter X; Müller R; Merino G; Bernèche S; Seelig A
    Biochemistry; 2015 Oct; 54(40):6195-206. PubMed ID: 26381710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-domain deleted factor VIII is aggregated and degraded through proteasomal and lysosomal pathways.
    Plantier JL; Guillet B; Ducasse C; Enjolras N; Rodriguez MH; Rolli V; Négrier C
    Thromb Haemost; 2005 May; 93(5):824-32. PubMed ID: 15886795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.